Pediatrix Medical (MD) Cash & Current Investments (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Cash & Current Investments data on file, last reported at $329.0 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $329.0 million, up 50.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $329.0 million (up 50.1% YoY), and the FY2025 annual result was $499.7 million, up 43.39% from the prior year.
• Cash & Current Investments eased to $329.0 million in Q1 2026 per MD's latest filing, from $499.7 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $499.7 million in Q4 2025 and troughed at $96.8 million in Q1 2022.
• A 5-year average of $211.4 million and a median of $133.2 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 78.84% in 2022, then jumped 161.51% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $103.1 million in 2022, then surged by 72.46% to $177.7 million in 2023, then surged by 96.07% to $348.5 million in 2024, then surged by 43.39% to $499.7 million in 2025, then sank by 34.17% to $329.0 million in 2026.
• Business Quant data shows MD's Cash & Current Investments at $329.0 million in Q1 2026, $499.7 million in Q4 2025, and $463.1 million in Q3 2025.